it means the primary molecular target has not been definitively established
People who otherwise might have skipped the GLP-1 injectable drugs might be more interested now, since some weight loss drugs are now available in pill form
Generally, in L-NAME non-responsive, L-arginine responsive NO-response in both circumstances, BPC 157s beneficial therapeutic effect (antagonization) goes over L-arginine (antagonization)
What makes this particularly worth paying attention to is how slowly some of these deficiencies reveal themselves
Management: Increase fiber and water intake
As counteraction was generally seen peripherally and centrally [14,15,16,20,22,23,24,25], it might also be possible in rats with an occluded bile duct